James E. Garrett

3.9k total citations
51 papers, 3.1k citations indexed

About

James E. Garrett is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, James E. Garrett has authored 51 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 8 papers in Oncology. Recurrent topics in James E. Garrett's work include Nicotinic Acetylcholine Receptors Study (16 papers), Receptor Mechanisms and Signaling (14 papers) and Ion channel regulation and function (11 papers). James E. Garrett is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (16 papers), Receptor Mechanisms and Signaling (14 papers) and Ion channel regulation and function (11 papers). James E. Garrett collaborates with scholars based in United States, Germany and Australia. James E. Garrett's co-authors include Baldomero M. Olivera, Doju Yoshikami, Cara L. Wellman, J. Michael McIntosh, Lance G. Hammerland, Maren Watkins, Edward M. Brown, James Douglass, Edward F. Nemeth and Cheryl Dowell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

James E. Garrett

49 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
James E. Garrett 2.1k 559 523 310 308 51 3.1k
Mariel Birnbaumer 2.1k 1.0× 791 1.4× 41 0.1× 152 0.5× 65 0.2× 44 3.1k
Laurent Taupenot 1.9k 0.9× 1.0k 1.8× 30 0.1× 128 0.4× 263 0.9× 70 3.3k
Lucy Rhee 3.6k 1.7× 1.8k 3.2× 35 0.1× 203 0.7× 283 0.9× 13 4.8k
Ariel J. Caride 1.4k 0.7× 333 0.6× 54 0.1× 156 0.5× 143 0.5× 61 2.2k
Michael S. Jackson 1.8k 0.9× 1.1k 1.9× 172 0.3× 108 0.3× 268 0.9× 123 4.4k
Käthi Geering 3.3k 1.6× 441 0.8× 146 0.3× 289 0.9× 190 0.6× 64 4.2k
W. C. Gunther 1.8k 0.9× 766 1.4× 152 0.3× 138 0.4× 93 0.3× 27 2.3k
Ivan Gautschi 3.8k 1.8× 328 0.6× 201 0.4× 504 1.6× 74 0.2× 37 4.3k
Eileen R. Mulvihill 2.7k 1.3× 2.5k 4.6× 35 0.1× 281 0.9× 141 0.5× 47 4.7k
Hemin Chin 2.1k 1.0× 1.2k 2.2× 26 0.0× 63 0.2× 134 0.4× 45 3.1k

Countries citing papers authored by James E. Garrett

Since Specialization
Citations

This map shows the geographic impact of James E. Garrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Garrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Garrett more than expected).

Fields of papers citing papers by James E. Garrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Garrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Garrett. The network helps show where James E. Garrett may publish in the future.

Co-authorship network of co-authors of James E. Garrett

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Garrett. A scholar is included among the top collaborators of James E. Garrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Garrett. James E. Garrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tawbi, Hussein A., Caroline Robert, Jan C. Brase, et al.. (2022). Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i). Journal for ImmunoTherapy of Cancer. 10(6). e004226–e004226. 19 indexed citations
2.
Wiggins, Jennifer, Georgina V. Long, Keith T. Flaherty, et al.. (2021). Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study. The Lancet Oncology. 22(3). 370–380. 70 indexed citations
3.
Dummer, Reinhard, Jan C. Brase, James E. Garrett, et al.. (2020). Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial. The Lancet Oncology. 21(3). 358–372. 85 indexed citations
4.
Long, Georgina V., Axel Hauschild, Mario Santinami, et al.. (2018). Updated relapse-free survival (RFS) and biomarker analysis in the COMBI-AD trial of adjuvant dabrafenib + trametinib (D + T) in patients (pts) with resected BRAF V600–mutant stage III melanoma. Annals of Oncology. 29. viii734–viii735. 13 indexed citations
5.
Chen, Ping, James E. Garrett, Maren Watkins, & Baldomero M. Olivera. (2008). Purification and characterization of a novel excitatory peptide from Conus distans venom that defines a novel gene superfamily of conotoxins. Toxicon. 52(1). 139–145. 15 indexed citations
6.
Bayrhuber, Monika, Roland Graf, Markus Zweckstetter, et al.. (2006). Production of recombinant Conkunitzin-S1 in Escherichia coli. Protein Expression and Purification. 47(2). 640–644. 19 indexed citations
7.
Garrett, James E., Olga Buczek, Maren Watkins, Baldomero M. Olivera, & Grzegorz Bułaj. (2005). Biochemical and gene expression analyses of conotoxins in Conus textile venom ducts. Biochemical and Biophysical Research Communications. 328(1). 362–367. 30 indexed citations
8.
Bayrhuber, Monika, Vinesh Vijayan, Roland Graf, et al.. (2005). Conkunitzin-S1 Is the First Member of a New Kunitz-type Neurotoxin Family. Journal of Biological Chemistry. 280(25). 23766–23770. 87 indexed citations
9.
McIntosh, J. Michael, Layla Azam, Cheryl Dowell, et al.. (2004). Analogs of α-Conotoxin MII Are Selective for α6-Containing Nicotinic Acetylcholine Receptors. Molecular Pharmacology. 65(4). 944–952. 170 indexed citations
10.
McIntosh, J. Michael, Cheryl Dowell, Maren Watkins, et al.. (2002). α-Conotoxin GIC from Conus geographus, a Novel Peptide Antagonist of Nicotinic Acetylcholine Receptors. Journal of Biological Chemistry. 277(37). 33610–33615. 97 indexed citations
11.
McIntosh, J. Michael, Stephanie M. Gardner, Siqin Luo, James E. Garrett, & Doju Yoshikami. (2000). Conus peptides: novel probes for nicotinic acetylcholine receptor structure and function. European Journal of Pharmacology. 393(1-3). 205–208. 42 indexed citations
12.
McIntosh, J. Michael, Gloria P. Corpuz, Richard T. Layer, et al.. (2000). Isolation and Characterization of a Novel ConusPeptide with Apparent Antinociceptive Activity. Journal of Biological Chemistry. 275(42). 32391–32397. 84 indexed citations
13.
Heath, Hunter, Shannon J. Odelberg, Charles E. Jackson, et al.. (1996). Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.. The Journal of Clinical Endocrinology & Metabolism. 81(4). 1312–1317. 135 indexed citations
14.
Garrett, James E., Lance G. Hammerland, Edward M. Brown, et al.. (1995). Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs. Journal of Biological Chemistry. 270(21). 12919–12925. 406 indexed citations
15.
Garrett, James E., et al.. (1991). In situ histochemical analysis of region‐specific gene expression in the adult rat epididymis. Molecular Reproduction and Development. 30(1). 1–17. 35 indexed citations
16.
Douglass, J, et al.. (1991). Transcriptional Regulation of the Rat Prodynorphin Gene. PsycEXTRA Dataset. 111. 133–48. 1 indexed citations
17.
Garrett, James E., et al.. (1990). A Spermatozoa-Associated Factor Regulates Proenkephalin Gene Expression in the Rat Epididymis. Molecular Endocrinology. 4(1). 108–118. 77 indexed citations
18.
Garrett, James E., Deborah S. Knutzon, & Dana Carroll. (1989). Composite Transposable Elements in the Xenopus laevis Genome. Molecular and Cellular Biology. 9(7). 3017–3027. 16 indexed citations
19.
Garrett, James E. & James Douglass. (1989). Human Chorionic Gonadotropin Regulates Expression of the Proenkephalin Gene in Adult Rat Leydig Cells. Molecular Endocrinology. 3(12). 2093–2100. 20 indexed citations
20.
Kelly, Martin J., James E. Garrett, Martha A. Bosch, et al.. (1989). Effects of Ovariectomy on GnRH mRNA, proGnRH and GnRH Levels in the Preoptic Hypothalamus of the Female Rat. Neuroendocrinology. 49(1). 88–97. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariel Birnbaumer Breakdown of academic impact, for papers by Laurent Taupenot Breakdown of academic impact, for papers by Lucy Rhee Breakdown of academic impact, for papers by Ariel J. Caride Breakdown of academic impact, for papers by Michael S. Jackson Breakdown of academic impact, for papers by Käthi Geering Breakdown of academic impact, for papers by W. C. Gunther Breakdown of academic impact, for papers by Ivan Gautschi Breakdown of academic impact, for papers by Eileen R. Mulvihill Breakdown of academic impact, for papers by Hemin Chin
Rankless by CCL
2026